Supplemental Material - Comparison of comorbidities and adverse events in dermatology and rheumatology patients prescribed tofacitinib: a retrospective analysis
Published: 21 November 2023| Version 2 | DOI: 10.17632/wbvrdw2x2x.2
Contributors:
, , , , , , , , , , Description
Supplemental methods and results for the publication entitled, “Comparison of comorbidities and adverse events in dermatology and rheumatology patients prescribed tofacitinib: a retrospective analysis.”
Files
Institutions
NYU Langone Health
Categories
Dermatology, Infectious Disease, Rheumatology, Adverse Effect of Drug, Drug Safety, Janus Kinase